We are pleased to announce that our client, Amphion Medical Solutions, Inc. (or “Amphion”), a provider of transcription, coding and quality measures abstraction services, has been acquired by iMedX, Inc., a leader in health information and clinical documentation.
Amphion was founded as one of the first “remote-only” coding companies and has established a superior approach to quality and bottom-line performance that has enabled the company to grow and offer broader technology and services across the health information management spectrum. The acquisition by iMedX will achieve scale, management depth, and a diversity of offerings that will create a leading, world-class medical documentation organization.
Mike Cavill, CEO of Amphion, says, “Throughout the process, Cascadia remained a trusted partner and valued advisor in assisting Amphion evaluate its strategic options and ultimately consummating a successful transaction with iMedX.”
Cascadia Capital acted as the exclusive financial advisor to Amphion. The acquisition follows on the heels of other recent transactions completed by Cascadia in both the Healthcare and Technology-enabled services sectors. The transaction also represents the second Madison, Wisconsin-based client Cascadia has successfully advised in the last two years, with the prior transaction involving Cascadia’s representation of Emdat, Inc. in its sale to Nuance.